| Redefining fatty liver disease: an international patient perspective G Shiha, M Korenjak, W Eskridge, T Casanovas, P Velez-Moller, ... The lancet Gastroenterology & hepatology 6 (1), 73-79, 2021 | 193 | 2021 |
| A global research priority agenda to advance public health responses to fatty liver disease JV Lazarus, HE Mark, AM Allen, JP Arab, P Carrieri, M Noureddin, ... Journal of hepatology 79 (3), 618-634, 2023 | 64 | 2023 |
| Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease ZM Younossi, SA Alqahtani, K Alswat, Y Yilmaz, C Keklikkiran, ... Journal of hepatology 80 (3), 419-430, 2024 | 54 | 2024 |
| Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective W Eskridge, DR Cryer, JM Schattenberg, A Gastaldelli, H Malhi, AM Allen, ... Journal of Clinical Medicine 12 (19), 6216, 2023 | 27 | 2023 |
| Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration … W Eskridge, JM Vierling, W Gosbee, GA Wan, ML Hyunh, HE Chang PLoS One 16 (11), e0260320, 2021 | 22 | 2021 |
| The Impact of Stigma on Quality of Life and Liver Disease Burden Among Patients with Nonalcoholic Fatty Liver Disease ZM Younossi, SA AlQahtani, J Funuyet-Salas, M Romero-Gómez, ... JHEP Reports, 101066, 2024 | 6 | 2024 |
| the Global NASH Council ZM Younossi, JGF YY, VWS Wong, M El-Kassas, S Zelber-Sagi, AM Allen, ... Stigma in NAFLD and NASH: A Global Survey of Patients and Providers, 2023 | 6 | 2023 |
| Stigma in NAFLD and NASH: a global survey of patients and providers Z Younossi, Y Yılmaz, JG Fan, VWS Wong, M El Kassas, S Zelber-Sagi, ... J Hepatol 78 (78), S627-S628, 2023 | 5 | 2023 |
| coreNASH: Multi‐stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment E Clearfield, V Miller, J Nadglowski, K Barradas, J Al Naber, AJ Sanyal, ... Hepatology communications 5 (5), 774-785, 2021 | 5 | 2021 |
| GROUP, NNC 2023a. A multi-society Delphi consensus statement on new fatty liver disease nomenclature ME RINELLA, JV LAZARUS, V RATZIU, SM FRANCQUE, AJ SANYAL, ... Hepatology, 0 | 3 | |
| A NOVEL PATIENT DECISION AID SYSTEM FOR EARLY RISK STRATIFICATION IN NAFLD: METHODOLOGY, AND RESULTS A Hall, JG Stine, W Eskridge, HE Chang, N Mistry, J Oosterbroek, A Kim, ... HEPATOLOGY 78, S752-S753, 2023 | | 2023 |
| EVOLVING TRENDS IN NAFLD/NASH PATIENT EXPERIENCES: COMPARATIVE ANALYSIS FROM" THE STATE OF NAFLD/NASH CARE IN AMERICA" 2022-2023 SURVEYS N Mistry, W Eskridge, HE Chang, T Mensah, D Evans HEPATOLOGY 78, S954-S956, 2023 | | 2023 |
| Stigma is a Predictor of Impairment of Health Related Quality of Life among Patients with NAFLD ZM Younossi, Y Yilmaz, JG Fan, MH Zheng, K Alswat, SA Alqahtani, ... AASLD The Liver Meeting 2023, 2023 | | 2023 |
| The Global Survey of Disease Burden and Stigma in NAFLD ZM Younossi, Y Yilmaz, JG Fan, MH Zheng, K Alsawat, SA Alqahtani, ... AASLD The Liver Meeting 2023, 2023 | | 2023 |
| AN ANNUAL SURVEY OF PATIENT PERSPECTIVES TO UNDERSTAND AND MONITOR THE EVOLVING SOCIAL AND MEDICAL EXPERIENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS (NAFLD) IN THE … N Mistry, W Eskridge, HE Chang, G Wan, D Evans HEPATOLOGY 76, S750-S751, 2022 | | 2022 |
| Liver disease, the Swiss army knife of comorbidity: A patient perspective from the grass roots W Eskridge Endocrinology, Diabetes & Metabolism 3 (4), 2020 | | 2020 |
